The current study was designed with the aim of conducting a systematic review and meta-analysis to determine the circulating levels of visfatin in patients with chronic obstructive pulmonary disease (COPD) compared to healthy individuals. The gene discussed is NAMPT; the disease is chronic obstructive pulmonary disease.